Applying a clinical lens to animal models of CAR-T cell therapies

Chimeric antigen receptor (CAR)-T cells have emerged as a promising treatment modality for various hematologic and solid malignancies over the past decade. Animal models remain the cornerstone of pre-clinical evaluation of human CAR-T cell products and are generally required by regulatory agencies p...

Full description

Bibliographic Details
Main Authors: Brynn B. Duncan, Cynthia E. Dunbar, Kazusa Ishii
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Molecular Therapy: Methods & Clinical Development
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2329050122001188